This inventor holds 1 USPTO granted patent. Top assignee: Eyegene Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Oh Woong Kwon: Innovator in Retinopathy Treatment
Introduction
Oh Woong Kwon is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical treatments, particularly in addressing eye conditions such as retinopathy and glaucoma. His innovative work has led to the development of a unique composition that utilizes thrombin-derived peptides.
Latest Patents
Oh Woong Kwon holds 1 patent for his invention titled "Composition for treating retinopathy or glaucoma comprising thrombin derived peptides." This patent discloses a composition that effectively treats retinopathy by incorporating thrombin-derived peptides as a key component.
Career Highlights
Kwon is currently associated with Eyegene Inc., a company that focuses on advancing medical technologies and treatments. His work at Eyegene Inc. has allowed him to explore and develop innovative solutions for eye health.
Collaborations
Some of his notable coworkers include Jin Wook Jang and Hyeong Joon Lim, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Oh Woong Kwon's contributions to the field of ophthalmology through his innovative patent demonstrate his commitment to improving medical treatments for eye conditions. His work continues to inspire advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile